SOPHiA GENETICS (SOPH) Raw Materials (2020 - 2021)
SOPHiA GENETICS (SOPH) posted Raw Materials of $5.1 million for Q4 2021, up 57.17% sequentially from $3.2 million in Q4 2020, and up 57.17% YoY from $3.2 million in Q4 2020.
SOPHiA GENETICS (SOPH) Raw Materials (2020 - 2021) Analysis & Trends
SOPHiA GENETICS has reported Raw Materials for 2 years, with the latest figure at $5.1 million in Q4 2021.
- Quarterly Raw Materials rose 57.17% year-over-year to $5.1 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $5.1 million (up 57.17% YoY) and the FY2021 annual result came in at $5.1 million, up 57.17% from the prior year.
- Raw Materials grew to $5.1 million in Q4 2021 per SOPH's latest filing, from $3.2 million in the prior quarter.
- Over five years, Raw Materials peaked at $5.1 million in Q4 2021 and troughed at $3.2 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn |
| 10 | SOPHiA GENETICS | 553.79 Mn | 446.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5.11 Mn |
| Dec 31, 2020 | 3.25 Mn |